188 related articles for article (PubMed ID: 35030348)
1. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review.
Thi Chung Duong T; Nguyen THN; Thi Ngoc Nguyen T; Huynh LH; Ngo HP; Thi Nguyen H
Cancer Epidemiol; 2022 Apr; 77():102097. PubMed ID: 35030348
[TBL] [Abstract][Full Text] [Related]
2. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
3. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200 families and prognostic value in various carcinomas: A systematic review and meta-analysis.
Yin Y; Song WW; Wang Y; Zhao W; Wu J; Xu W
Aging Med (Milton); 2018 Jun; 1(1):39-45. PubMed ID: 31942478
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
Wu B; Zhen K; Guo L; Sun C
Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
[No Abstract] [Full Text] [Related]
6. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
7. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
8. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis.
Shi M; Mu Y; Zhang H; Liu M; Wan J; Qin X; Li C
Medicine (Baltimore); 2018 Aug; 97(32):e11505. PubMed ID: 30095616
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
Pan F; Mao H; Deng L; Li G; Geng P
Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200 Family Profile: A Promising Ancillary Tool for Accurate Cancer Diagnosis.
Liu X; Zhang J; Xie B; Li H; Shen J; Chen J
Am J Ther; 2016; 23(2):e388-97. PubMed ID: 26618619
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis.
Wang L; Liu Y; Lyu C; Buchner A; Pohla H
Biomed Res Int; 2021; 2021():8851035. PubMed ID: 33614788
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer.
Fischer C; Deutsch TM; Feisst M; Rippinger N; Riedel F; Hartkopf AD; Brucker SY; Domschke C; Fremd C; Michel L; Burwinkel B; Schneeweiss A; Turchinovich A; Wallwiener M
Arch Gynecol Obstet; 2022 Sep; 306(3):875-885. PubMed ID: 35237856
[TBL] [Abstract][Full Text] [Related]
16. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis.
Sun C; Zhu J; Wu B; Chen J; Zhu Z; Cai P; Guo W; Gu Z; Wang J; Huang S
Cancer Manag Res; 2018; 10():2125-2139. PubMed ID: 30050323
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Zhan B; Lu D; Luo P; Wang B
Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
Peng Z; Duan F; Yin J; Feng Y; Yang Z; Shang J
J Transl Med; 2019 Oct; 17(1):347. PubMed ID: 31640738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
